PA SB1067

Expands the definition of "epinephrine auto-injector" to "epinephrine delivery system" to include any FDA-approved device containing a premeasured, weight-based dose of epinephrine for treating life-threatening allergic reactions

Requires day-care facilities (child care centers and family child care homes) to acquire and stock epinephrine delivery systems, subject to designated funding being provided to the Department of Health

Mandates that day-care facility employees complete anaphylaxis training and immediately notify parents/guardians if a child experiences anaphylaxis while in care

Requires the Department of Health, in consultation with the Department of Human Services, to develop informational materials about allergic reactions for day-care facilities to distribute to parents within 90 days of enactment

Extends existing Good Samaritan liability protections to day-care facilities and their employees who administer epinephrine delivery systems in good faith, with the act taking effect in 180 days